Skip to content
healthcare.dev

Hypothalmupar

NDC 44911-0473, Aralia Quinquefolia, Ginkgo Biloba, Hydrocotyle Asiatica, Cerebrum Suis, Hypophysis Suis, Hypothalamus Suis, Phosphorus, Silicea, liquid, from Energique, Inc..

Product NDC
44911-0473
Status
Listed
Labeler
Energique, Inc.
Dosage form
LIQUID
Route
ORAL
Product type
HUMAN OTC DRUG
Marketing category
UNAPPROVED HOMEOPATHIC
Application
—
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/44911-0473 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • AMERICAN GINSENG3 [hp_X]/mL
  • GINKGO3 [hp_X]/mL
  • CENTELLA ASIATICA WHOLE3 [hp_X]/mL
  • SUS SCROFA CEREBRUM8 [hp_X]/mL
  • SUS SCROFA PITUITARY GLAND8 [hp_X]/mL
  • SUS SCROFA HYPOTHALAMUS12 [hp_X]/mL
  • PHOSPHORUS12 [hp_X]/mL
  • SILICON DIOXIDE12 [hp_X]/mL
Package NDCNDC-11Package
44911-0473-14491104730130 mL in 1 BOTTLE, DROPPER (44911-0473-1)

Linked data

RxNorm, label and prices

RxNorm concepts

RxNorm links no concept to this product's packages.

Related lookups

No FDA label, Medicare Part B payment limit or NADAC price is linked to this product.

Use it

Look up 44911-0473 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/44911-0473 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 44911-0473. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.